Copyright
©The Author(s) 1998.
World J Gastroenterol. Oct 15, 1998; 4(5): 421-425
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.421
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.421
Figure 5 SDS-PAGE and Western blot.
A. Fas transfectants, B. anti -Bcl-2 transfectants. a. SGC7901/VCR/3 × 106 cells, b. SGC7901/3 × 106 cells, c. High molecular weight protein marker, d. SGC7901-Fas/VCR/1 × 106 cells, e. SGC7901-Fas/VCR/2 × 106 cells, f. SGC7901/1 × 106 cells, g. SGC7901/2 × 106 cells, h. SGC7901/VCR/1 × 106 cells, i. SGC7901/VCR/2 × 106 cells, j. Middle molecular weight protein marker, k. SGC7901 anti Bcl-2/VCR/5 × 105 cells, l. SGC7901 anti-Bcl-2/VCR/1 × 106 cells, m. SGC7901 anti-Bcl-2/ VCR/2 × 106 cells, n. SGC7901 anti Bcl-2/VCR/3 × 106 cells
- Citation: Xiao B, Shi YQ, Zhao YQ, You H, Wang ZY, Liu XL, Yin F, Qiao TD, Fan DM. Transduction of Fas gene or Bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs. World J Gastroenterol 1998; 4(5): 421-425
- URL: https://www.wjgnet.com/1007-9327/full/v4/i5/421.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.i5.421